BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12093764)

  • 1. Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids.
    Chen Z; Fukutomi T; Zago AC; Ehlers R; Detmers PA; Wright SD; Rogers C; Simon DI
    Circulation; 2002 Jul; 106(1):20-3. PubMed ID: 12093764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.
    Indolfi C; Cioppa A; Stabile E; Di Lorenzo E; Esposito G; Pisani A; Leccia A; Cavuto L; Stingone AM; Chieffo A; Capozzolo C; Chiariello M
    J Am Coll Cardiol; 2000 Jan; 35(1):214-21. PubMed ID: 10636283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a role of macrophage migration inhibitory factor in vascular disease.
    Chen Z; Sakuma M; Zago AC; Zhang X; Shi C; Leng L; Mizue Y; Bucala R; Simon D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):709-14. PubMed ID: 14751814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
    Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
    Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.
    Janardhanan R; Yang B; Vohra P; Roy B; Withers S; Bhattacharya S; Mandrekar J; Kong H; Leof EB; Mukhopadhyay D; Misra S
    Kidney Int; 2013 Aug; 84(2):338-52. PubMed ID: 23636169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.
    Walter DH; Rittig K; Bahlmann FH; Kirchmair R; Silver M; Murayama T; Nishimura H; Losordo DW; Asahara T; Isner JM
    Circulation; 2002 Jun; 105(25):3017-24. PubMed ID: 12081997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering.
    Wilson SH; Herrmann J; Lerman LO; Holmes DR; Napoli C; Ritman EL; Lerman A
    Circulation; 2002 Jan; 105(4):415-8. PubMed ID: 11815421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
    Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
    Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin reduces leucocyte- and platelet-endothelial cell interaction in murine antigen-induced arthritis in vivo.
    Gottschalk O; Dao Trong ML; Metz P; Wallmichrath J; Piltz S; Jauch KW; Jansson V; Schmitt-Sody M
    Scand J Rheumatol; 2014; 43(5):356-63. PubMed ID: 24825390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection.
    Lee TS; Chang CC; Zhu Y; Shyy JY
    Circulation; 2004 Sep; 110(10):1296-302. PubMed ID: 15337692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase reduces leukocyte recruitment and hepatocyte apoptosis in endotoxin-induced liver injury.
    Slotta JE; Laschke MW; Wang Y; Schilling MK; Menger MD; Thorlacius H
    J Investig Med; 2009 Jun; 57(5):645-9. PubMed ID: 19289970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K; Pineda G; Newton RS; Fernandez ML
    Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.
    Liang H; Chaparro-Riggers J; Strop P; Geng T; Sutton JE; Tsai D; Bai L; Abdiche Y; Dilley J; Yu J; Wu S; Chin SM; Lee NA; Rossi A; Lin JC; Rajpal A; Pons J; Shelton DL
    J Pharmacol Exp Ther; 2012 Feb; 340(2):228-36. PubMed ID: 22019884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy: beyond cholesterol lowering and antiinflammatory effects.
    Yeung AC; Tsao P
    Circulation; 2002 Jun; 105(25):2937-8. PubMed ID: 12081982
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.
    Mangravite LM; Medina MW; Cui J; Pressman S; Smith JD; Rieder MJ; Guo X; Nickerson DA; Rotter JI; Krauss RM
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1485-92. PubMed ID: 20413733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.
    Takahashi T; Ishii N; Itai K; Goto R; Higashi K; Kobori S
    J Atheroscler Thromb; 2005; 12(3):149-53. PubMed ID: 16020915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.